Sigachi Industries Limited

Equities

SIGACHI

INE0D0K01022

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:50 2024-05-10 am EDT 5-day change 1st Jan Change
64.75 INR -0.92% Intraday chart for Sigachi Industries Limited -0.77% +25.97%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sigachi Industries Limited Announces Resignation of Shreya Mitra as Company Secretary & Compliance Officer CI
Sigachi MENA FZCO Unit, iConsult Establish Joint Venture for UAE Business MT
Sigachi MENA FZCO, A Wholly Owned Subsidiary of the Sigachi Industries Limited and iConsult Trading Consultancy LLC Announce Formation of Joint Venture, Sigachi Global CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Sigachi Industries Limited announced that it has received INR 716.11875 million in funding from a group of investors CI
Sigachi Industries' Dubai-based Arm to Form Saudi Arabian JV MT
Sigachi Industries Limited Declares Dividend for the Financial Year 2022-23 CI
Sigachi Industries Sets Up New Corporate Office in Hyderabad, India MT
Sigachi Industries Limited Announces Opening of New Corporate Office CI
Sigachi Industries Limited Recommends Dividend for the Financial Year 2022-23 CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Sigachi Industries Limited agreed to acquire 80% stake in Trimax Bio Sciences Private Limited for INR 1 billion. CI
Sigachi Industries' Consolidated Profit Plummets in Fiscal Q4 MT
Sigachi Industries Limited Recommends Dividend CI
Sigachi Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Sigachi Looks to Acquire API Units for Forward Integration CI
Sigachi Industries Limited Announces Resignation of Mohankrishna Reddy Arvabumi as Director CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Sigachi Industries Limited Approves Board Changes CI
CARE Retains A- Rating on Sigachi Industries' Long-term Bank Financing; Outlook Stable MT
Certain Equity Shares of Sigachi Industries Limited are subject to a Lock-Up Agreement Ending on 10-NOV-2022. CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Sigachi Industries Limited Announces Launch of Health Care Division CI
Chart Sigachi Industries Limited
More charts
Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Company’s products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The Company's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. It produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The Company offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. It operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The Company serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.
More about the company
  1. Stock Market
  2. Equities
  3. SIGACHI Stock
  4. News Sigachi Industries Limited
  5. CARE Retains A- Rating on Sigachi Industries' Long-term Bank Financing; Outlook Stable
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW